Recombinant Human AITRL (TNFSF18) was expressed in E. coli cells.
Catalog No. A828-40N
Catalog No. | Pack Size | Price (USD) | |
---|---|---|---|
A828-40N-30 | 30 ug | $160 | |
A828-40N-200 | 200 ug | $865 | |
A828-40N-1000 | 1 mg | $3850 | |
A828-40N-BULK | BULK | Contact Us |
Overview:
TNFSF18 is a transmembrane glycoprotein which is expressed in vascular endothelial cells as well as neurons, antigen presenting cells, CD4- CD8- double negative thymic precursors, and in the eye. TNFSF18 works to mediate the interactions between T cells and endothelial cells, and T cell growth. It has been shown that TNFSF18's expression is transiently up-regulated by proinflammatory stimulation.
Gene Aliases:
Activation-inducible TNF-related ligand, AITRL, Glucocorticoid-induced TNF-related ligand, GITRL, hGITRL, Tumor necrosis factor ligand superfamily member 18, TNFSF18, TL-6, Recombinant Human Activation-Induced TNFR Member Ligand (TNFSF18).
Genbank Number:
Storage, Stability and Shipping:
The lyophilized protein is stable for at least one year from date of receipt at -70oC. Upon reconstitution, this cytokine can be stored in working aliquots at 2o - 8oC for one month, or at -20oC for six months, with a carrier protein without detectable loss of activity. Avoid repeated freeze/thaw cycles.
Endotoxin Level:
<1.0 EU/μg of recombinant protein as determined by the LAL method.
Molecular Weight:
14.2 kDa
Reconstitution Protocol:
Reconstitute at 0.1 mg/mL in PBS containing at least 0.1% human or bovine serum albumin.
Sample Cell Assay Data:
Purity:
Recombinant Human AITRL (TNFSF18) resolved on a 17% SDS-PAGE gel under reducing conditions and stained with Coomassie Brilliant Blue G-250.
There are no related publications available for this product.
Cancer
STAY CONNECTED
Fax: 1-604-232-4601